Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#17-776 Listing of Mini future issued by BNP Paribas Issuance B.V.

As from August 18, 2017, 1 Mini future issued by BNP Paribas Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Sweden AB. Issuer: BNP Paribas Issuance B.V. Type of security: Mini future, open ended Execution: Automatic cash settlement Term: As from August 18, 2017 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: Light Sweet Crude Oil (WTI) Futures Current values of strike and barrier can be found at: [ NGM Market Data Web -

#17-775 Listing of Turbo warrant issued by Commerzbank AG

As from August 18, 2017, 1 Turbo warrant issued by Commerzbank AG will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Sweden AB. Issuer: Commerzbank AG Type of security: Call Turbo warrant of European type Execution: Automatic cash settlement Term: As from August 18, 2017 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.

#17-381 Listing of Turbo warrant issued by Commerzbank AG

As from August 18, 2017, 1 Turbo warrant issued by Commerzbank AG will be listed on NDX Finland and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Finland Oy. Issuer: Commerzbank AG Type of security: Call Turbo warrant of European type Execution: Automatic cash settlement Term: As from August 18, 2017 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.

#17-380 Listing of Knock out warrant issued by Commerzbank AG

As from August 18, 2017, 1 Knock out warrant issued by Commerzbank AG will be listed on NDX Finland and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Finland Oy. Issuer: Commerzbank AG Type of security: Knock out warrant, open ended Execution: Automatic cash settlement Term: As from August 18, 2017 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

#17-31 Listing of Knock out warrants issued by Commerzbank AG

As from August 18, 2017, 8 Knock out warrants issued by Commerzbank AG will be listed on NDX Denmark and will be included on the list for Knock-Outs. The instruments will be registered at VP SECURITIES A/S. Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from August 18, 2017 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: ICE Brent Crude Oil Futures Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

Article about Nexam Chemical in Plastforum

In an article in the Swedish trade magazine Plastforum, CEO Anders Spetz and CSO Johan Arvidsson are interviewed about Nexam Chemical´s operations. The article can be found on Plastforum  (only in Swedish).Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com  _________________________________________________________

The world's most modern snack plant begins operations in Finland

The world's most modern snack plant comes into operation in Valio Riihimäki, Southern Finland. The inauguration of the dairy plant is being held today, 17 August. The plant uses the very latest environmentally-friendly technology. With the new plant and its modern technology, Valio's world-class product development expertise will be used to its full extent. Consumers will benefit from this in the form of innovative snack products.“Innovativeness, a wonderful taste, and responsible manufacturing practices. These are the things that people expect from their snacks, and our new snack plant

Knorr-Bremse welcomes decision by Haldex’ EGM to support offer

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdictions where such offer pursuant to legislation and regulations in such relevant jurisdictions would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important notice” at the end of this announcement and

#17-774 Recalculation of reference value for Vestas Wind Systems A/S

The reference value for BULL VESTAS X10 VON have been recalculated in accordance withthe instruments final terms. The instrument will be traded under observation for the rest of thetrading day. For more information concerning the recalculations, please contact the issuers of the affectedinstruments. For further information concerning this NDX notice please contact:NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM ABAbout NDXNordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527

Novel Bispecific Antibody Targeting Biological Pathway Implicated in Multiple Solid Tumor IndicationsSeattle, WA, and Lund, Sweden – August 17, 2017 – Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the companies have initiated CMC activities for the manufacturing of clinical material in preparation for a future investigational new

Etteplan OYJ: SHARE REPURCHASE 17.8.2017

Released:8/17/2017Category:Changes in company's own sharesEtteplan Oyj ANNOUNCEMENT 17.8.2017Etteplan OYJ: SHARE REPURCHASE 17.8.2017In the Helsinki Stock ExchangeTrade date 17.8.2017Bourse trade BuyShare ETTEAmount 1 300 SharesAverage price/share 8.6592 EURTotal cost 11 256.96 EUREtteplan Oyj now holds a total of 54 845 sharesincluding the shares repurchased on 17.8.2017On behalf of Etteplan OyjNordea Bank AB (publ), Finnish BranchJanne Sarvikivi Julius SummanenFor more information, please contact:Juha Näkki, President and CEOtel. +358 400 606 372Outi

Systemair's Interim Report for the first quarter will be presented on August 24

Press Release, 17 August 2017 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q1 for the financial year 2017/18 will be published at 13:00 CET on August 24, 2017.A telephone conference will be held at 13:30 CET on August 24, 2017. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference:Call +46 (0)8 5052 0337 and enter code 962658 minutes before start.The presentation will be published on www.systemair.com For further information contact:Roland Kasper, CEO, + 46 73 094 40 13, +46 222 440 13

Holmen’s interim report January–June 2017

Quarter  January–June Full Year     SEKm  2-17  1-17  2-16  2017 2016 2016 Net sales  4 148 4 131  3 937 8 278 7 765 15 513 Operating profit 525 627  483 1 152 1 063 2 162 excl.items affectingcomparability Operating   525 627  483 1 152 831 1 930 profit Profit after   394 485  364 880 587 1 424 tax Earnings per   4.7 5.8  4.3 10.5 7.0 16.9 share, SEK Operating   12.7 15.2  12.3 13.9 13.7 13.9

Axactor AB - Increase in share capital related to Tranche 1 of the Private Placement

Oslo, 17 August 2017 - Reference is made to the stock exchange announcement from Axactor AB ("Axactor" or the "Company") published 14 August 2017 regarding the successfully completed private placement of 240,000,000 new shares (the "Private Placement Shares") at a price of NOK 2.49 per share (the "Private Placement"). DNB Markets, a part of DNB Bank ASA, acted as manager for the Private Placement (the "Manager"). The Private Placement is divided into i) a Tranche 1 consisting of 75.6 million Private Placement Shares, and ii) a Tranche 2 consisting of 164.4 million Private Placement

Dry and clean air for medical ventilation devices

Oil-free compressed air supply by Dürr TechnikFor the supplying of compressed air for medical mechanical ventilators a proven compression technology at a very high level is needed. A reliable air compressor is therefore the heart of the ventilator.Dürr Technik’s oil-free compressors are successfully been used since the last 50 years in the Medical Industry. The SICOLAB med is a soundproofed, oil-free compressor station, which is generating compressed air for the supply of a ventilation device. It works by compaction of ambient air, which makes ventilation independent of central gas

Nel ASA: Invitation to presentation of Q2 2017 results

(Oslo, 17 August 2017) Nel ASA (Nel) will announce its second quarter 2017 report on Thursday 24 August at 07:00 CET and will host an open presentation at 08:00 CET.  Location: Hotel Continental, Oslo, Norway Time: 24 August 2017 at 08:00 CET Presenter: Jon André Løkke, CEO Nel ASA Language: English  The presentation will be broadcasted live at www.nelhydrogen.com and can also be viewed at http://webtv.hegnar.no/presentation.php?webcastId=58635400  The second quarter 2017 report and presentation will be made available through www.newsweb.no and www.nelhydrogen.com. ENDS

Interim Report January – June 2017

· Order intake was MSEK 2,700.4 (2,349.5), which is an overall growth of 14.9% adjusted to 1.3% for acquisitions (MSEK 296.8) and currency effects (MSEK 24.6)  · Net sales were MSEK 2,544.7 (2,172.6), which is an overall growth of 17.1% adjusted to 3.8% for acquisitions (MSEK 266.2) and currency effects (MSEK 23.3)  · Operating profit was MSEK 313.3 (238.9), representing a 31.1% increase with an operating margin of 12.3 (11.0)% · Earnings after tax were MSEK 216.5 (173.9), an increase of 24.5% · Earnings per share were SEK 1.90 (1.53)  · Cash flow from operating activities was

Kamux Oyj: Invitation to conference call of Kamux Corporation's half-year financial report for January-June 2017 on 24 August 2017

Kamux Oyj Investor News 17 August 2017 at 12:00 Invitation to conference call of Kamux Corporation's half-year financial report for January-June 2017 on 24 August 2017 Kamux Corporation will publish its half-year financial report for January-June 2017 on Thursday, 24 August 2017. We are pleased to invite you to join conference call on the same day at 14:30 (Finnish time).   Participation online: https://praecomspark.webex.com/praecomspark/onstage/g.php?MTID=e07749ed8fa031463905159af8a651a26 Click "Join Now".   To join audio conference only: Numbers: UK

Peab builds office building in Malmö

Peab has been commissioned to build an office building in Västra Hamnen in Malmö. The customer and general contractor is Midroc Projects AB and the contract is worth SEK 109 million.The office building will be seven stories high built on Propellergatan near Kockum Fritid in Västra Hamnen in Malmö. This is a turnkey contract. The project will begin in August 2017 and be completed in the spring of 2019.The project will be order registered in the third quarter 2017.For further information, please contact:Bratislav Marjanovic, Region Manager Peab, cell: +46 733 37 43 02Kajsa

Elite Asset Management Plc's subsidiary Elite Sijoitus Oy buys Auta Invest Oy and Smart Money Oy

Elite Asset Management Plc, Company Announcement, 17 August 2017 at 11:30 a.m. (EET) Elite Asset Management Plc's subsidiary Elite Sijoitus Oy buys Auta Invest Oy and Smart Money Oy Elite Asset Management Plc's subsidiary Elite Sijoitus Oy ("Elite") and the owners of Auta Invest Oy and Smart Money Oy have today signed two sale and purchase agreements by which Elite acquires all of both Auta Invest Oy's and Smart Money Oy's outstanding shares. The acquired companies act as tied agent companies marketing investment and asset management services. As a result of the acquisition, the

IRLAB signs agreement with TCTC to conduct Phase-2 study with IRL790

Development of IRLAB Therapeutics’ candidate drugs continues according to plan and an agreement has been signed with The Clinical Trial Company Ltd (TCTC) to conduct the planned Phase 2 study with the drug candidate IRL790. The study will be conducted at clinics in the UK. Thereby, IRLAB enters into Phase 2 studies with both their candidate drugs – IRL790 and IRL752 – during the autumn.The Phase 1b study regarding IRL790, which was concluded during spring 2017, provided positive and very valuable information about safety, tolerability, dosing and efficacy, supporting the planning of the

Invitation to Presentation of SimCorp’s H1 2017 Interim Report

SimCorp will publish its H1 2017 interim report to NASDAQ Copenhagen on Thursday, 24 August, 2017 at around 8:00 am (CEST). SimCorp’s Executive Management Board will present the report at a conference call the same day at 2:00 pm (CEST). Please use any of the following phone numbers to dial in to the conference call:  From Denmark:                    +45 3848 7513From USA:                           +1212 444 0412From other countries:           +44(0)20 3427 1904 The pin code to access the call is 5519392. At the end of the presentation there will be a Q&A session.It will

Trelleborg invests in high-end production for sealing solutions in Denmark

Trelleborg has, through its business area Trelleborg Sealing Solutions, decided to invest in a new state of the art production facility for sealing solutions in Denmark, thus relocating its current manufacturing facility in the country. The move is intended to transform and further expand the current capabilities of the existing facility to demonstrate future manufacturing principles and technologies that enable profitable sales growth. The investment forms part of Trelleborg’s strategy to strengthen positions in attractive market segments. “The Danish operation is one of our most

There are no items matching the current filter
There are no more items matching the current filter
Back to top